S. A. Popo6 et al. / Tetrahedron: Asymmetry 12 (2001) 2875–2881
2879
¥=20 mm, eluent CCl4, CCl4–EtOAc) to give 4a 250
mg (0.70 mmol, 36%) and 4b 180 mg (0.50 mmol, 26%).
(ddd, J=7.0, 6.6, 1.1, 1H-6), 1.74 (dd, J=6.6, 1.1,
1H-7), 1.03 (s, 3H-9); 0.61 (s, 3H-10), 3.79 (ddd, J=9.9,
9.9, 4.7, 1H-11), 3.58 (ddd, J=12.5, 9.4, 4.2, 1H-12),
2.06 (m, 1H-13a); 1.70–1.80 (m, 2H-15a, 14a), 1.25–1.37
(m, 3H-15b, 14b, 13b), 1.65 (m, 1H-16a), 1.99 (m,
1H-16b), 3.53 (br.s, 1H-OH). 13C NMR (125 MHz):
12.38 (C-1), 150.48 (C-2), 125.59 (C-3), 142.19 (C-4),
24.68 (C-5), 34.02 (C-6), 25.74 (C-7), 22.21 (C-8), 26.18
(C-9), 13.60 (C-10), 65.64 (C-11), 72.61 (C-12), 33.02
(C-13), 23.89 (C-14), 24.702 (C-15), 30.39 (C-16).
4.6. Synthesis of benzoate of pyrazole–cyclohexanol
9 and separation of the diastereomers
Benzoyl chloride 5.0 g (36 mmol) was added to a stirred
mixture of pyrazole 5 (4.3 g, 17 mmol) in CH2Cl2 (30
ml) and pyridine (10 g) and the mixture was allowed to
stay for 48 h. The mixture was sequentially washed with
satd aq. NaHCO3 (100 ml), 1.0 M H2SO4 (100 ml),
dried (Na2SO4) and concentrated under reduced pres-
sure. The resulting light brown viscous oil was dissolved
in MeCN (50 ml) and left in refrigerator. After 24 h
benzoate 9a (3.0 g, 45%) was separated as white crys-
tals. The mother liquor was evaporated to afford a
brownish oil, which contained benzoates 9b and 9a
(10:1 according to NMR) together with impurities.
4.10. (1R,2R)-2-((3bS,4aR)-3,4,4-Trimethyl-3b,4,4a,5-
tetrahydrocyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)-
cyclohexanol 5b
Treatment of 5 (4.5 g, 17 mmol) with benzoyl chloride
followed by separation of 9a (crystallization) resulted in
the mother liquor, which was concentrated and
saponified to give 5b (1.8 g, 40%) as white needles with
mp 131–133°C(MeCN) and [h]2D5=+66 (c 1.25, CHCl3).
1H NMR (500 MHz, CDCl3): 2.14 (s, 3H-1), 2.50 (ddd,
J=16.6, 1.3, 1.6, 1H-5a), 2.80 (dd, J=16.6, 7.0, 1H-
5b), 1.68 (ddd, J=7.0, 6.5, 1.3, 1H-6), 1.75 (dd, J=6.5,
1.6, 1H-7), 1.07 (s, 3H-9), 0.63 (s, 3H-10), 3.80 (ddd,
J=10.5, 9.5, 4.8, 1H-11), 3.56 (ddd, J=12.3, 9.4, 4.2,
1H-12), 1.35 (m, 1H-13a), 2.08 (m, 1H-13b), 1.32 (m,
1H-14a), 1.77 (m, 1H-14b), 1.30 (m, 1H-15a), 1.78 (m,
1H-15b), 1.66 (dddd, J=12.5, 12.5, 12.5, 3.9, 1H-16ax),
1.99 (m, 1H-16eq), 3.36 (br.s, W1/2=90, 1H-OH). 13C
NMR (125 MHz): 12.45 (C-1), 150.58 (C-2), 125.50
(C-3), 142.14 (C-4), 24.66 (C-5), 34.11 (C-6), 25.95
(C-7), 22.27 (C-8), 26.31 (C-9), 13.68 (C-10), 65.68
(C-11), 72.52 (C-12), 33.15 (C-13), 24.05 (C-14), 24.90
(C-15), 30.47 (C-16). IR, UV, and MS data were identi-
cal to those of 5a.
4.7. Saponification of benzoates 9a and 9b
A solution of 9a (1.0 g, 2.7 mmol) or solution of the
mother liquor (1.0 g) in MeOH (10 ml) and KOH (1 g,
17.8 mmol) were heated at 70°C for 1 h. The mixture
was evaporated at reduced pressure. Water (40 ml) was
added to the residue and the mixture was extracted with
CCl4 (2×20 ml). The combined organic extracts were
washed with 1 M aq. H2SO4 (3×15 ml). The combined
aqueous extracts were neutralized with conc. aq. NH3
(20 ml) and extracted with CH2Cl2 (3×15 ml) to afford
a solid, which was crystallized from MeCN to give
pyrazolocyclohexanol as pale yellow crystals.
4.8.(1S,2S)-2-((3bS,4aR)-3,4,4-Trimethyl-3b,4,4a,5-tetra-
hydrocyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)cyclo-
hexanol and (1R,2R)-2-((3bS,4aR)3,4,4-trimethyl-
3b,4,4a,5-tetrahydrocyclopropa[3,4]cyclopenta[1,2-c]-
pyrazol-1-yl)cyclohexanol 5
4.11. (1S,2S)-Benzoic acid-2-((3bS,4aR)-3,4,4-trimethyl-
3b,4,4a,5-tetrahydrocyclopropa[3,4]cyclopenta[1,2-c]-
pyrazol-1-yl)cyclohexyl ester 9a
Reaction of diketone 1 (1.65 g, 10.0 mmol) with 2-
hydrazinocyclohexanol led to
a
mixture of
Treatment of 5 (4.5 g, 17 mmol) with benzoyl chloride
followed by crystallization of the crude product 9 from
MeCN led to 9a (2.9 g, 46%) as white needles with mp
167–169°C (MeCN, dec.) and [h]2D1=+179 (c 1.7,
CHCl3). UV (EtOH) umax/nm 231 (m 17000); 269 (m 900).
IR (CHCl3) w/cm−1 1716 (CꢁO). MS (m/z, %): 364.2143
(M+, 45%, C23H28N2O2, requires 364.2151), 349 (79),
259 (28), 242 (11), 227 (93), 201 (10), 173 (4), 161 (24),
diastereomers 5 (2.20 g, 84%) as yellow crystals. Heat-
ing a mixture of pyrazole 3 (R=H) (3.6 g, 2.2 mmol)
and cyclohexene oxide led to a mixture of pyrazoles 5
and 8 (5.44 g, 95%, 5:8=10:1 according to NMR and
GC–MS).
4.9. (1S,2S)-2-((3bS,4aR)-3,4,4-Trimethyl-3b,4,4a,5-tet-
rahydrocyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)-
cyclohexanol 5a
1
147 (98), 132 (7), 105 (100), 77 (54), 41 (13). H NMR
(CCl4–CDCl3, 200 MHz): 2.05 s (3H-1), 2.48 d (J=
16.0, 1H-5a), 2.77 dd (J=16.0, 7.0, 1H-5b), 2.32 m
(1H), 1.1–1.71 m (5H), 1.75–2.1 m (4H), 3.96 m (1H-
11), 5.22 m (1H-12); aromatic protons: 7.25–7.50 m
(3H), 7.80–7.90 m (2H). 13C NMR (50 MHz): 12.28
(C-1), 149.34 (C-2), 124.72 (C-3), 141.33 (C-4), 23.69
(C-5), 33.77 (C-6), 25.99 (C-7), 21.98 (C-8), 26.11 (C-9),
13.33 (C-10), 62.06 (C-11), 74.49 (C-12), 31.41 (C-13),
23.69 (C-14), 24.61 (C-15), 31.20 (C-16), 164.55 (CꢁO),
aromatic carbons: 127.67 d (2C), 129.34 d (2C), 130.20
s (1C), 132.15 d (1C).
Saponification of benzoate 9a (2.9 g, 8.0 mmol) led to
5a (2.0 g, 96%) as white crystals with mp 138–140°C
(MeCN). [h]2D5=+102 (c 1.0, CHCl3). MS (m/z, %):
260.18886 (M+, 35%, C16H24N2O, requires 260.18885);
245 (73), 227 (28), 217 (3), 189 (3), 175 (30), 163 (55),
147 (100), 133 (7), 120 (3), 106 (8), 91 (7), 81 (9), 65 (3),
55 (3), 45 (4). IR (CHCl3) w/cm−1 3592, 3346, 1551,
1518; 1485, 1451; 1432, 1373, 1333, 1291, 1262, 1215;
1173, 1121, 1072, 1045, 982. IR (CHCl3) w/cm−1 3592
1
(OꢀH). UV (EtOH) umax/nm 238 (m 5300). H NMR
(500 MHz, CDCl3): 2.14 (s, 3H-1), 2.52 (ddd, J=16.8,
1.1, 1.1, 1H-5a), 2.75 (dd, J=16.8, 7.0, 1H-5b), 1.67
4.11.1. Crystal data for 9a. C23H28N2O2, M=364.47,
monoclinic, space group P21, a=5.8010(8), b=